{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:36:31Z","timestamp":1762508191897,"version":"3.41.2"},"reference-count":28,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Reviews in Medical Virology"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>SARS\u2010CoV\u20102 has caused a pandemic which is putting strain on the health\u2010care system and global economy. There is much pressure to develop both preventative and curative therapies for SARS\u2010CoV\u20102 as there is no evidence to support therapies to improve outcomes in patients with SARS\u2010CoV\u20102. Medications that inhibit certain steps of virus life cycle that are currently used to treat other illnesses such as Malaria, Ebola, HIV and Hepatitis C are being studied for use against SARS\u2010CoV\u20102. To date, data is limited for medications that facilitate clinical improvement of COVID\u201019 infections.<\/jats:p>","DOI":"10.1002\/rmv.2136","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T14:51:07Z","timestamp":1594306267000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID\u201019) and the rationale for their utilization: A review"],"prefix":"10.1002","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8547-2693","authenticated-orcid":false,"given":"Richard A.","family":"Giovane","sequence":"first","affiliation":[{"name":"Department of Family Medicine Regional Medical Center of Central Alabama  Greenville Alabama USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8498-565X","authenticated-orcid":false,"given":"Shadi","family":"Rezai","sequence":"additional","affiliation":[{"name":"Department of OB\/GYN Valley Community Healthcare  North Hollywood California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Cleland","sequence":"additional","affiliation":[{"name":"Department of Family Medicine University of Alabama  Tuscaloosa Alabama USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassandra E.","family":"Henderson","sequence":"additional","affiliation":[{"name":"Garden OB\/GYN Mercy Medical Center  New York New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30114-5"},{"key":"e_1_2_5_3_1","unstructured":"World Health Organization.Advice on the use of masks in the context of the novel coronavirus (2019\u2010nCoV) outbreak. April 6 2020.https:\/\/www.who.int\/publications-detail\/advice-on-the-use-of-masks-in-the-community-during-home-care-and-in-healthcare-settings-in-the-context-of-the-novel-coronavirus-(2019-ncov)-outbreak. Accessed April 7 2020."},{"key":"e_1_2_5_4_1","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/results?cond=COVID&term=BCG&cntry=&state=&city=&dist="},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-2438-7_1"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00645-06"},{"issue":"18","key":"e_1_2_5_7_1","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID\u201019): a review","volume":"323","author":"Sanders JM","year":"2020","journal-title":"JAMA"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"issue":"8","key":"e_1_2_5_9_1","article-title":"Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China","volume":"70","author":"Wang Z","year":"2020","journal-title":"Clin Infect Dis"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"e_1_2_5_11_1","doi-asserted-by":"crossref","unstructured":"ColsonP RolainJM LagierJC BrouquiP RaoultD.Chloroquine and hydroxychloroquine as available weapons to fight COVID\u201019. Published online March 4 2020.","DOI":"10.1016\/j.ijantimicag.2020.105932"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25898"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4742"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282"},{"issue":"6","key":"e_1_2_5_15_1","first-page":"399","article-title":"Treatment of severe acute respiratory syndrome with lopinavir\/ritonavir: a multicentre retrospective matched cohort study","volume":"9","author":"Chan KS","year":"2003","journal-title":"Hong Kong Med J"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002535"},{"key":"e_1_2_5_17_1","article-title":"Favipiravir versus Arbidol for COVID\u201019: a randomized clinical trial","author":"Chen C","year":"2020","journal-title":"medRxiv"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071039"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030343"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00221-18"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0282-0"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007016"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25801"},{"issue":"20","key":"e_1_2_5_24_1","first-page":"10970","article-title":"Effective treatment of severe COVID\u201019 patients with tocilizumab","volume":"117","author":"Xu X","year":"2020","journal-title":"ChinaXiv"},{"issue":"3","key":"e_1_2_5_25_1","first-page":"e7343","article-title":"Acetazolamide, Nifedipine and phosphodiesterase inhibitors: rationale for their utilization as adjunctive countermeasures in the treatment of coronavirus disease 2019 (COVID\u201019)","volume":"12","author":"Solaimanzadeh I","year":"2020","journal-title":"Cureus"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.01572.2005"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1152\/advan.00054.2009"},{"key":"e_1_2_5_28_1","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04321096."},{"issue":"4","key":"e_1_2_5_29_1","article-title":"Hypoxaemia related to COVID\u201019: vascular and perfusion abnormalities on dual\u2010energy CT","volume":"20","author":"Lang M","year":"2020","journal-title":"Lancet Infect Dis"}],"container-title":["Reviews in Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Frmv.2136","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rmv.2136","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rmv.2136","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rmv.2136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T07:31:37Z","timestamp":1693899097000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/rmv.2136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1002\/rmv.2136"],"URL":"https:\/\/doi.org\/10.1002\/rmv.2136","archive":["Portico"],"relation":{},"ISSN":["1052-9276","1099-1654"],"issn-type":[{"type":"print","value":"1052-9276"},{"type":"electronic","value":"1099-1654"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"assertion":[{"value":"2020-04-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2136"}}